Search - tctmd.com

Displaying 661 - 680 of 832

Sort: Relevancy | Date

News Conference News TCT 2014

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

September 16, 2014

News Industry News

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

September 16, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation

September 16, 2014

Presentation TCT 2014

AF Ablation: Stand-Alone and in Conjunction with LAA Closure

Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, Vivek Y. Reddy

September 15, 2014

Presentation TCT 2014

Percutaneous Left Atrial Appendage Closure for Atrial Fibrillation: Where Are We Compared to New Drugs and Ablation

Presenter: Jose Luis Assad-Morell, Efrain Gaxiola, Matthew J. Price

September 13, 2014

Presentation TCT 2014

Essentials of Chemical Ablation

Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Tim A. Fischell

September 13, 2014

Presentation TCT 2014

Essentials of Ultrasound Ablation

Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Joost Daemen

September 13, 2014

Presentation TCT 2014

Essentials of Radiofrequency Ablation (Irrigated and Nonirrigated, Monopolar and Bipolar)

Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Vivek Y. Reddy

September 13, 2014

Presentation TCT 2014

Preclinical Insights Into the Optimal Ablation Location for Renal Denervation Procedures

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Robert J. Melder

September 13, 2014

Presentation TCT 2014

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Rami Tzafriri

September 13, 2014

News Industry News

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

September 13, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

September 13, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation Therapy

September 13, 2014

News Industry News

St. Jude Medical Announces CE Mark Approval and First Use of the FlexAbility Ablation Catheter

July 22, 2014

Presentation LAA 2014

Electrical Approaches to AF Ablation: Acute & Sustained Success, Complications

Presenter: Vivek Y. Reddy

July 17, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Industry News

Cardiostim Symposium Demonstrates BIOTRONIK Home Monitoring® Advantages for Effective Management of Heart Failure Patients

June 19, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

Advertisement

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

Experts Debate Future of Renal Denervation

AF Ablation: Stand-Alone and in Conjunction with LAA Closure

Percutaneous Left Atrial Appendage Closure for Atrial Fibrillation: Where Are We Compared to New Drugs and Ablation

Essentials of Chemical Ablation

Essentials of Ultrasound Ablation

Essentials of Radiofrequency Ablation (Irrigated and Nonirrigated, Monopolar and Bipolar)

Preclinical Insights Into the Optimal Ablation Location for Renal Denervation Procedures

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

Experts Debate Future of Renal Denervation Therapy

St. Jude Medical Announces CE Mark Approval and First Use of the FlexAbility Ablation Catheter

Electrical Approaches to AF Ablation: Acute & Sustained Success, Complications

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Cardiostim Symposium Demonstrates BIOTRONIK Home Monitoring® Advantages for Effective Management of Heart Failure Patients

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content